Visit the Resource Centre to view the latest publications, presentations, and more from scientists using nanopore sequencing to research COVID-19.Įxtending COVID-19 research: metagenomics, epigenetics, and immune response Starter pack and bundle options are available, providing everything you need to start sequencing, whether you're new to nanopore sequencing or getting started with SARS-CoV-2 analysis, at low cost per sample. Making use of fast, streamlined library preparation methods, real-time nanopore sequencing and data streaming, and highly scalable nanopore sequencing technology, these workflows enable you to set up SARS-CoV-2 sequencing quickly and easily in your own lab. Their foundational work, and that of Nikki Freed and Olin Silander, form the core of the workflows available for the nanopore sequencing of SARS-CoV-2. Oxford Nanopore have worked closely with the ARTIC Network, who have developed workflows for the rapid preparation and sequencing of SARS-CoV-2 whole genomes in use by scientists around the world. This experience has supported the rapid deployment of nanopore sequencing in the COVID-19 pandemic. The unique features of nanopore technology have enabled its use by the scientific community for the rapid sequencing of pathogens in multiple outbreak situations, including Zika, Ebola, yellow fever, and swine flu. Why nanopore for SARS-CoV-2 whole-genome sequencing? This can help indicate, or rule out, routes of transmission, enable identification and investigation of clusters, and help inform strategies to control the spread of the virus. Determine how strains of the virus are related. These may impact the nature of the disease caused by the virus, or inform future treatment strategies and vaccine design. Quickly identify variants and track their prevalence and distribution.In combination with rapid data sharing across the scientific community, this enables genomic epidemiological analysis, which has become a key part of the global public health response to the COVID-19 pandemic.īy rapidly sequencing and sharing SARS-CoV-2 genomic data, it is possible to: Scientists around the world are using nanopore sequencing to rapidly sequence and analyse SARS-CoV-2 virus genomes. Genomic epidemiology is the study of how variations in the genomes of pathogens, or their hosts, influence health and disease, including how common specific variations are, how they interact with environmental factors, and how they contribute to disease risk.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |